Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-002465

President and CEO acquired 658 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanjiv President and CEO 2021-12-31 Grant or award +658 $26.10 $17,174 253,740 D
Loading xslF345X03/doc4.xml…